Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BRAINTREE, Mass., July 29, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported first quarter fiscal 2014 net revenue of $219.5 million, up 24%, a GAAP net loss of $7.9 million and a loss per share of $0.15. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $23.8 million, up 46%, and adjusted earnings per share were $0.46, up 46%. Excluding currency impact, net revenue was up 29% in the quarter.(1) On an organic basis revenue declined 5% in the quarter and 2% on a constant currency basis.
Help employers find you! Check out all the jobs and post your resume.
